Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancersFrançoise Derouane(Cliniques Universitaires Saint-Luc), Cyril Corbet(IMEC)Breast Cancer ResearchFebruary 19, 202410.1186/s13058-024-01788-8Cited by 23SaveCiteExport RISWatch citationsRelated PapersTGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells|Nature Communications|2020|318Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine|Cancers|2022|89MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy|Cancer Letters|2024|26